J&J Fined €25M Over French Generic Drug Smear Campaign
France's antitrust enforcer fined Johnson & Johnson and its Janssen-Cilag unit €25 million ($29.7 million) on Wednesday for hindering the marketing and sale of a generic version of the company's Durogesic...To view the full article, register now.
Already a subscriber? Click here to view full article